Fusion Antibodies (FAB) Stock Chart & Stock Price History GBX 14 +0.25 (+1.82%) As of 12:43 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock Fusion Antibodies Stock Price Performance The Fusion Antibodies (FAB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 225.58%, with a year-to-date return of 95.53%. In the past month, the stock has decreased 15.10%, reflecting recent market activity. As of the latest close, Fusion Antibodies traded at GBX 13.77 with a market cap of £15.65 million and volume of 1.91 million shares. Five years ago, the stock traded at GBX 199.75, representing a 92.99% decrease over that period. At the time, it had a market cap of £36.25 million and a volume of 266,612 shares. Receive FAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fusion Antibodies and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-12.47%1 Month Performance-15.10%3 Month Performance+116.55%Year-To-Date Performance+95.53%1 Year Performance+225.58%5 Year Performance-92.99% FAB Stock Chart for Friday, October, 10, 2025 FAB Chart by TradingView Fusion Antibodies Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/09/2025GBX 15.18GBX 13.77-9.26%GBX 15.50GBX 131.91 million shs£15.65 million10/08/2025GBX 15.37GBX 15.18-1.27%GBX 17GBX 142.10 million shs£17.25 million10/07/2025GBX 15.88GBX 15.37-3.21%GBX 16.50GBX 15833,703 shs£17.47 million10/06/2025GBX 16GBX 15.88-0.72%GBX 16.50GBX 15889,831 shs£18.05 million10/03/2025GBX 17.27GBX 16-7.38%GBX 17.50GBX 15.651.26 million shs£18.18 million10/02/2025GBX 17GBX 17.27+1.59%GBX 17.50GBX 16.50885,677 shs£19.63 million10/01/2025GBX 17.88GBX 17-4.92%GBX 17.99GBX 16.501.58 million shs£19.32 million09/30/2025GBX 18.99GBX 17.88-5.85%GBX 19.50GBX 17.501.33 million shs£20.32 million09/29/2025GBX 18.50GBX 18.99+2.68%GBX 19.50GBX 18.151.56 million shs£21.58 million09/26/2025GBX 18.49GBX 18.50+0.03%GBX 19GBX 16.602.79 million shs£21.02 million Get the Latest News and Ratings for FAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fusion Antibodies and its competitors with MarketBeat's FREE daily newsletter. 09/25/2025GBX 18.99GBX 18.49-2.63%GBX 18.49GBX 17.502.50 million shs£21.02 million09/24/2025GBX 18.56GBX 18.99+2.34%GBX 21GBX 18.132.13 million shs£21.58 million09/23/2025GBX 17.92GBX 18.56+3.54%GBX 19GBX 171.44 million shs£21.09 million09/22/2025GBX 17.18GBX 17.92+4.31%GBX 18GBX 16.501.29 million shs£20.37 million09/19/2025GBX 16.40GBX 17.18+4.76%GBX 17.70GBX 161.50 million shs£19.53 million09/18/2025GBX 17.80GBX 16.40-7.85%GBX 17.80GBX 163.72 million shs£18.64 million09/17/2025GBX 14GBX 17.80+27.13%GBX 19GBX 14.505.92 million shs£20.23 million09/16/2025GBX 15.50GBX 14-9.65%GBX 14.50GBX 13.502.54 million shs£15.91 million09/15/2025GBX 15.99GBX 15.50-3.10%GBX 17GBX 151.95 million shs£17.61 million09/12/2025GBX 15.83GBX 15.99+1.01%GBX 16.15GBX 15.16752,308 shs£18.17 million09/11/2025GBX 16.49GBX 15.83-4.00%GBX 16.49GBX 15.511.03 million shs£17.99 million09/10/2025GBX 15.99GBX 16.49+3.13%GBX 17.50GBX 15.752.01 million shs£18.74 million09/09/2025GBX 14.16GBX 15.99+12.92%GBX 16GBX 14.221.35 million shs£18.17 million Related Companies ImmuPharma Stock Price Chart Hemogenyx Pharmaceuticals Stock Price Chart hVIVO Stock Price Chart SkinBioTherapeutics Stock Price Chart Sareum Stock Price Chart Arecor Therapeutics Stock Price Chart Poolbeg Pharma Stock Price Chart Aptamer Group Stock Price Chart IXICO Stock Price Chart OptiBiotix Health Stock Price Chart Receive FAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fusion Antibodies and its competitors with MarketBeat's FREE daily newsletter. This page (LON:FAB) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fusion Antibodies plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Fusion Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
